Updated Date:
11 Mar 2026
Product Detail:
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
Shortage Status:
Current
AUST R:
203313
Availability:
Limited Availability
Active Ingredient:
clevidipine
Reason:
Transport / Logistic issues / Storage capacity issues
Dosage Form:
Injection,emulsion
Supply Impact Dates
From 10 Mar 2026
To 31 Jul 2026
Management Action:
An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
